Unintentional acetaminophen ingestion in children and the potential for hepatotoxicity

E M Caravati1

  • 1Utah Poison Control Center and Division of Emergency Medicine, University of Utah Health Sciences Center, Salt Lake City 84108, USA. martin.caravati@hsc.utah.edu

Insights

Children ingesting 140-200 mg/kg of acetaminophen may be managed at home if vomiting occurs within 60 minutes. Higher doses or unknown amounts require medical evaluation for potential acetaminophen toxicity.

Area of Science:

  • Pediatric Toxicology
  • Emergency Medicine
  • Pharmacology

Background:

  • Unintentional acetaminophen ingestion in children frequently leads to healthcare evaluations.
  • Current referral criteria lack specificity, resulting in many non-toxic exposures.
  • Defining precise criteria is crucial for appropriate medical management.

Purpose of the Study:

  • To determine the incidence of potentially hepatotoxic serum concentrations in pediatric acetaminophen ingestions.
  • To establish clearer referral guidelines for children who have ingested acetaminophen.

Main Methods:

  • Prospective evaluation of 1015 children (1-72 months) with single acetaminophen ingestions.
  • Referral for ingestions ≥140 mg/kg or unknown amounts; ipecac advised for >100 mg/kg within 1 hour.
  • Hepatotoxicity assessed using the Rumack-Matthew nomogram.

Main Results:

  • Six patients (0.59%) had possible/probable hepatotoxic concentrations, all ingesting >200 mg/kg or unknown amounts.
  • No potentially hepatotoxic concentrations were found in 423 patients ingesting 100-200 mg/kg.
  • 81% of patients with higher ingestions received decontamination interventions.

Conclusions:

  • Children ingesting 140-200 mg/kg with ipecac-induced emesis within 60 minutes can be managed at home.
  • Referral for serum acetaminophen concentration is recommended for ingestions >200 mg/kg or unknown amounts.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...